Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PLCH1 antisense RNA 1 (PLCH1-AS1) is a long non-coding RNA (lncRNA) transcribed from the antisense strand at the PLCH1 locus. Like other antisense lncRNAs, PLCH1-AS1 does not encode a protein but instead can influence the expression of genes nearby (in cis) or elsewhere in the genome (in trans) through a variety of mechanisms, including chromatin remodeling, interaction with regulatory proteins, and modulation of transcriptional interference. These RNAs are recognized as important regulators of gene expression and chromatin states across diverse biological processes, but there are currently no published studies linking PLCH1-AS1 specifically to therapeutic targeting, validated disease mechanisms, or clinical interventions[1][3]. As a member of the antisense long non-coding RNA molecular class, it may play regulatory roles in development, stress response, or disease contexts like cancer—yet, as of now, there is a lack of disease- or drug-association data for PLCH1-AS1 specifically[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PLCH1 antisense RNA 1 (PLCH1-AS1).